Plain-English translation of NCT07684131 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study — meaning researchers will collect and track information from patients like you who are already receiving standard treatment for Philadelphia chromosome-positive acute lymphoblastic leukemia. The study focuses on patients being treated with BCR::ABL1 inhibitors combined with chemotherapy, corticosteroids, and/or a monoclonal antibody. By gathering real-world data about how these combination treatments work, researchers hope to better understand outcomes and improve care for future patients.
Philadelphia chromosome-positive acute lymphoblastic leukemia is a serious form of blood cancer, and doctors now treat it with several medications working together. This study exists to collect information from patients receiving this combination treatment in order to understand what works best and help improve treatment strategies.
You likely qualify if…
You likely don't qualify if…
As a participant, you would continue your regular cancer treatment with your doctors. The research team would collect information from your medical records about your diagnosis, the medications you're taking, and how you're responding to treatment over time. This is not a treatment study — you're not starting anything new, but rather helping researchers learn from your existing care.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
France